Thirty Candida albicans isolated from oral candidosis patients and 30 C. albicans isolated from control individuals were studied. In vitro susceptibility tests were performed for amphotericin B, fluconazole, 5-flucytosine and itraconazole through the Clinical and Laboratorial Standards Institute (CLSI) reference method and E test system. The results obtained were analyzed and compared. MIC values were similar for the strains isolated from oral candidosis patients and control individuals. The agreement rate for the two methods was 66.67% for amphotericin B, 53.33% for fluconazole, 65% for flucytosine and 45% for itraconazole. According to our data, E test method could be an alternative to trial routine susceptibility testing due to its simplicity. However, it can not be considered a substitute for the CLSI reference method.
INTRODUCTION
Candida albicans is a commensal yeast of the normal oral microbiota. However, several local and systemic factors can predispose to the development of oral candidosis. Thus, conditions such as age extremes, immunodeficiency, endocrine disorders, radiotherapy, malignant diseases, xerostomia, denture wearing, poor oral hygiene and orthodontic treatment can be cited as predisposing factors 4, 12, 19, 22 . Nystatin and amphotericin B are common therapeutic agents for oropharyngeal candidosis 21 . The increasing number of clinical isolates resistant to antifungal therapy, as well as the necessity of a guide to the selection and follow-up of the treatment led to a demand for susceptibility testing of fungi 13 . For this purpose, the Clinical and Laboratorial Standards Institute (CLSI) approved a reference method for antifungal susceptibility testing of yeasts, the National Committee for Clinical and Laboratorial Standards (NCCLS) M-27 A2 document 14 . The E test 1 has been introduced as an easier testing procedure and an alternative for the NCCLS method 2, 6, 15, 17, 20, 23 . The great advantage of E test is the simplicity of the methodology. However, not all antifungal agents are available in E test and there is a difficulty associated with endpoint interpretation, due to the growth of micro-colonies in the inhibition zone, leading to lower reproducibility when the test is performed by several technicians. The aim of this study was to compare the results of fluconazole, itraconazole, flucytosine and amphotericin B susceptibility testing of C. albicans oral strains obtained by the CLSI reference method and the E test.
MATERIALS AND METHODS
Isolates: Thirty Candida albicans isolated from denture-associated oral candidosis patients and 30 from control individuals were studied. The patients with candidosis were randomly selected among the patients of the Prosthetics Department of São José dos Campos Faculty of Dentistry (University of the State of São Paulo-UNESP, São Paulo, Brazil). No patient was under treatment with antifungal drugs. The individuals from the control group were randomly selected among students from this University. Patients with basis diseases or smokers or under medication were excluded. The strains were isolated from saliva and identified by biochemical, physiological and morphological tests. Candida spp. strains were transferred onto Sabouraud dextrose agar (Difco Laboratories, Detroit, USA) and stored at 4 °C. C. albicans strains were transferred onto fresh Sabouraud dextrose agar (Difco Laboratories, Detroit, USA) slants 24 hours prior the realization of antifungal susceptibility testing.
Susceptibility testing:
1. NCCLS reference method: The susceptibility assays were determined by the microbroth dilution method performed in sterile flatbottom 96-well microplates (Difco Laboratories, Detroit, USA) as described previously in NCCLS guidelines, M-27 A document (NCCLS, 2002) . Briefly, isolates were inoculated at 35 °C and observed at 24 and 48 hours. Five colonies greater than 1 mm in diameter were selected, suspended in saline solution and adjusted to a final concentration of 0.5 x 10 3 to 2.5 x 10 3 in RPMI 1640 medium (Sigma, St. Louis, USA) buffered to pH 7.0 with 0.165M morpholinepropanesulfonic acid (MOPS; Sigma). The antifungal agents fluconazole (Pfizer, São Paulo, Brazil), itraconazole (Janssen Pharmaceutica, São Paulo, Brazil), amphotericin B (Sigma) and flucytosine (5-fluorocytosine; Hoffman La Roche, Basel, Switzerland) were used in the susceptibility tests. Amphotericin B and itraconazole were dissolved in dimethylsulfoxide. Fluconazole and flucytosine were dissolved in sterile distilled water. The drugs were prepared at the following concentrations: 320 µg/mL for amphotericin B, 1000 µg/mL for flucytosine, 1250 µg/mL for fluconazole and 640 µg/ mL for itraconazole. The solutions were diluted in RPMI medium and final drugs concentrations ranged from 32 to 0.04 µg/mL for amphotericin B, 64 to 0.04 µg/mL for itraconazole, 25 to 0.02 µg/mL for flucytosine and 128 to 0.06 µg/mL for fluconazole. After 48 hours of incubation at 35 °C, MIC (minimum inhibitory concentration) was determined visually by comparing its turbidity with the drug-free growth control well. For the azoles and flucytosine the MIC values were defined as the lower drug concentration which resulted in reduction of 80% in the turbidity in comparison with the drug-free growth control well and for amphotericin B the MIC value was defined as the lowest drug concentration for which the well was optically clear.
2. E test (AB Biodisk, Solna, Sweden): The E test was performed according to the manufacturer's instructions (AB Biodisk, 1993). In brief, the inoculum concentration was adjusted to 0.5 in McFarland standard for Candida species. Then, 0.5 mL of this suspension was inoculated onto plates containing RPMI 1640 agar (1.5%) with 2% glucose using a cotton swab. After a period of 15 minutes, the E test strips were applied. The antifungal drugs amphotericin B, itraconazole, fluconazole, and flucytosine were tested. The plates were incubated at 35 °C and read after 24 and 48 hours.
Analysis of the results:
The MICs (minimum inhibitory concentration) at which 50% (MIC 50 ) and 90% (MIC 90 ) of the isolates were inhibited were determined for each drug. A comparison between the results obtained by the NCCLS reference method and E test was performed. The rate of agreement was represented as proposed by SEWELL et al. (1994) in terms of percentage of agreement. It was considered agreement when MIC results of E test and NCCLS method were in exact agreement or were within ± 2 two-fold dilutions. The results were descriptively analyzed.
RESULTS
The MIC ranges and values of MIC 50 and MIC 90 obtained for amphotericin B, fluconazole, itraconazole and flucytosine susceptibility testings determined by NCCLS method and E test are summarized in Table 1 and 2, respectively. MIC values were similar for the strains isolated from oral candidosis patients and control individuals. The comparison of the MICs values obtained by NCCLS reference method and E test at 24 h and 48 h were compared and the percentages of agreement are presented in Table 3 .
DISCUSSION
The comparison between E test and CLSI methodology has been studied by several authors. Earlier studies related a good agreement between the NCCLS reference microdilution method and the E test for the azoles susceptibility testing. In these researches, the agreement percentages varied from 71 to 85.2% for ketoconazole 6, 9 , from 80 to 96% to fluconazole 7, 20, 23 and from 80 to 84% for itraconazole. However, in more recent publications, authors related poorer agreement percentages between these two susceptibility testing methods. KOC et al. 9 and MARTIN-MAZUELOS 11 related percentages of 74-79% for fluconazole. For itraconazole, MARTIN-MAZUELOS 11 obtained 61.4% of agreement.
In the present study, poor agreement was observed for fluconazole (53.33%) and itraconazole (45%) at 24 hours. Additionally, agreement observed at 48 hours was even worst. ESPINEL-INGROFF 7 also related a poorer agreement after 48 hours of incubation in comparison with results observed in 24 hours.
The determination of the endpoints for the azoles is a significant factor in the variability of MIC results. The partial growth inhibition makes it difficult to determine MIC values accurately 3, 18 . The same person always performed the interpretation of MIC results in the CLSI method. Similarly, to avoid variability in endpoint readings due to the difficulty in define the borders of inhibition zone in the E test method, the same person scored all the plates. PFALLER et al. 16 obtained the best agreement between the NCCLS reference method and the E test using the RPMI agar with 2% glucose. For this reason, all E test experiments were performed with this type of medium.
For amphotericin B susceptibility testing, good correlation was observed between the tested methods at 24h (66.67%) and 48 hours. Interestingly, best agreement percentage was observed after 48 hours (71.67%). VAN ELDERE et al. 23 and KOC et al. 9 also related good agreement rates that varied from 90 to 96%.
For flucytosine, a good agreement between the NCCLS method and E test was observed at 24 hours (65%). These results are in accordance to those obtained by CHANG et al. 5 and ISHIGAKI et al. The present study demonstrated a lower percentage of agreement between the methodologies tested than other studies found in literature. The discrepancy might be due to interlaboratory differences or to the use of different media for E test methodology. This fact reinforces the importance of tests standardization. On the other hand, it is relevant to notice that the evaluator was not blind regarding the test or for the antifungal agent evaluated, which might be considered a limitation of the present work.
Minimmum inhibitory concentrations obtained in the present study were similar for control samples and samples obtained from candidosis patients. A higher MIC could possibly be expected for candidosis patients, since virulence factors such as exoenzyme production have been correlated with antifungal resistance 10 .
In conclusion, E test method could be considered an alternative to trial routine susceptibility testing due to its simplicity. However, it can not be considered, at this moment, a substitute for NCCLS reference method, since a complete agreement between both methodologies has not been reached, as demonstrated by the present study and corroborated by others presented in literature. Due to the numerous variables associated to the E test method, further studies must be performed to standardize the medium and incubation conditions. Moreover, studies on the correlation of in vitro antifungal susceptibility testing and clinical response to these drugs are essentially important. 
RESUMO

